IL17A and hydrops fetalis: The results of KEGG pathway enrichment analysis also demonstrate that the therapeutic effect of TFDM on HF may be achieved by inhibiting the IL-17 signaling pathway, TNF signaling pathway, NF-kappa B signaling pathway, etc. Inflammation is accepted as an important pathophysiological factor in HF.